Metabolic genes CYP1B1, AANAT, ADH5, and ALDH3A2, associated with the serotonin and melatonin biosynthesis pathway, contribute to tumour growth, immune modulation, and altered metabolic states in the TME (Figure S6). Here, ALDH3A2 is linked to neoplasm.